Employee benefits survey finds marked increase in GLP-1 coverage (NYSE:LLY)

US employers are increasingly covering GLP-1 drugs for diabetes and weight loss, with utilization management helping to control costs, according to a new survey.

Related Keywords

,International Foundation Of Employee Benefit ,International Foundation ,Employee Benefit Plans ,Novo Nordisk ,Eli Lilly ,